BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38555324)

  • 21. 5-methylcytosine and 5-hydroxymethylcytosine in brains of patients with multiple system atrophy and patients with Parkinson's disease.
    Kaut O; Kuchelmeister K; Moehl C; Wüllner U
    J Chem Neuroanat; 2019 Mar; 96():41-48. PubMed ID: 30557654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered Global 5-Hydroxymethylation Status in Hidradenitis Suppurativa: Support for an Epigenetic Background.
    Hessam S; Sand M; Lang K; Käfferlein HU; Scholl L; Gambichler T; Skrygan M; Brüning T; Stockfleth E; Bechara FG
    Dermatology; 2017; 233(2-3):129-135. PubMed ID: 28750404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors.
    Larson AR; Dresser KA; Zhan Q; Lezcano C; Woda BA; Yosufi B; Thompson JF; Scolyer RA; Mihm MC; Shi YG; Murphy GF; Lian CG
    Mod Pathol; 2014 Jul; 27(7):936-44. PubMed ID: 24390216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The metabolism of 5-methylcytosine residues in DNA.
    Murín R; Abdalla M; Murínová N; Hatok J; Dobrota D
    Physiol Res; 2018 Jul; 67(3):383-389. PubMed ID: 29527909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location-dependent patterns of genetic and epigenetic alterations.
    Jurmeister P; Wrede N; Hoffmann I; Vollbrecht C; Heim D; Hummel M; Wolkenstein P; Koch I; Heynol V; Schmitt WD; Thieme A; Teichmann D; Sers C; von Deimling A; Thierauf JC; von Laffert M; Klauschen F; Capper D
    J Pathol; 2022 Jan; 256(1):61-70. PubMed ID: 34564861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cul4b Promotes Progression of Malignant Cutaneous Melanoma Patients by Regulating CDKN2A.
    Zhang C; Cao C; Liu XL; Jun T; Liu P
    Tohoku J Exp Med; 2021 May; 254(1):33-39. PubMed ID: 34011786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma.
    Wouters J; Vizoso M; Martinez-Cardus A; Carmona FJ; Govaere O; Laguna T; Joseph J; Dynoodt P; Aura C; Foth M; Cloots R; van den Hurk K; Balint B; Murphy IG; McDermott EW; Sheahan K; Jirström K; Nodin B; Mallya-Udupi G; van den Oord JJ; Gallagher WM; Esteller M
    BMC Med; 2017 Jun; 15(1):101. PubMed ID: 28578692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.
    Scala S; Ottaiano A; Ascierto PA; Cavalli M; Simeone E; Giuliano P; Napolitano M; Franco R; Botti G; Castello G
    Clin Cancer Res; 2005 Mar; 11(5):1835-41. PubMed ID: 15756007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor/semaphorin-3A ratio and SEMA3A expression in cutaneous malignant melanoma.
    Lucarini G; Simonetti O; Lazzarini R; Giantomassi F; Goteri G; Offidani A
    Melanoma Res; 2020 Oct; 30(5):433-442. PubMed ID: 32516239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global DNA methylation status in laryngeal cancer.
    Stembalska A; Leszczyński P; Gil J; Ramsey D; Pitala G; Maciejczyk A; Frączek M
    Head Neck; 2014 Mar; 36(3):419-24. PubMed ID: 23729003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic biomarkers in skin cancer.
    Greenberg ES; Chong KK; Huynh KT; Tanaka R; Hoon DS
    Cancer Lett; 2014 Jan; 342(2):170-7. PubMed ID: 22289720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GLT8D1 overexpression as a novel prognostic biomarker in human cutaneous melanoma.
    Hu H; Li Z; Zhou Y; Zhang Y; Zhao L; Zhao W; Huang Y; Song X
    Melanoma Res; 2019 Dec; 29(6):612-620. PubMed ID: 31305325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of lymphocyte-activating gene 3 and T-cell immunoreceptor with immunoglobulin and ITIM domains in cutaneous melanoma and their correlation with programmed cell death 1 expression in tumor-infiltrating lymphocytes.
    Lee WJ; Lee YJ; Choi ME; Yun KA; Won CH; Lee MW; Choi JH; Chang SE
    J Am Acad Dermatol; 2019 Jul; 81(1):219-227. PubMed ID: 30880064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global DNA hypomethylation is an early event in Helicobacter pylori-related gastric carcinogenesis.
    Compare D; Rocco A; Liguori E; D'Armiento FP; Persico G; Masone S; Coppola-Bottazzi E; Suriani R; Romano M; Nardone G
    J Clin Pathol; 2011 Aug; 64(8):677-82. PubMed ID: 21617174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients.
    Venza M; Visalli M; Catalano T; Beninati C; Teti D; Venza I
    Hum Pathol; 2017 Feb; 60():137-146. PubMed ID: 27825810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes.
    Poloni A; Goteri G; Zizzi A; Serrani F; Trappolini S; Costantini B; Mariani M; Olivieri A; Catarini M; Centurioni R; Alesiani F; Giantomassi F; Stramazzotti D; Biagetti S; Alfonsi S; Berardinelli E; Leoni P
    Eur J Haematol; 2013 Sep; 91(3):219-227. PubMed ID: 23679560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic markers of prognosis in melanoma.
    Sigalotti L; Fratta E; Parisi G; Coral S; Maio M
    Methods Mol Biol; 2014; 1102():481-99. PubMed ID: 24258994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma.
    Huynh KT; Takei Y; Kuo C; Scolyer RA; Murali R; Chong K; Takeshima L; Sim MS; Morton DL; Turner RR; Thompson JF; Hoon DS
    Br J Dermatol; 2012 Jun; 166(6):1319-26. PubMed ID: 22293026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a 5-methylcytosine-Related Molecular Signature to Inform the Prognosis and Immunotherapy of Lung Squamous Cell Carcinoma.
    He R; Feng X; Yang K; Zhou X; Li W; Zeng J
    Expert Rev Mol Diagn; 2022 Sep; 22(9):905-913. PubMed ID: 36197838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of 5-methylcytosine and 5-hydroxymethylcytosine in human placenta cell types across gestation.
    Wilson RL; François M; Jankovic-Karasoulos T; McAninch D; McCullough D; Leifert WR; Roberts CT; Bianco-Miotto T
    Epigenetics; 2019 Jul; 14(7):660-671. PubMed ID: 31038385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.